Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance

Vaccine

Volumn 33, Issue 32, 2015, Pages 3894-3899

  Burgess, Timothy H ^a   Murray, Clinton K ^b   Bavaro, Mary F ^c   Landrum, Michael L ^b,d   O'Bryan, Thomas A ^b,d   Rosas, Jessica G ^b,d   Cammarata, Stephanie M ^c,d   Martin, Nicholas J ^e   Ewing, Daniel ^e   Raviprakash, Kanakatte ^e   Mor, Deepika ^d   Zell, Elizabeth R ^f   Wilkins, Kenneth J ^g   Millar, Eugene V ^d  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e NAVAL MEDICAL RESEARCH CENTER   (United States)

^f Stat Epi Associates Inc   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Influenza; Military; Self administration; Vaccine

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; LIVE VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FEMALE; HEALTH CARE PERSONNEL; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MALE; MASS IMMUNIZATION; MILITARY DEPLOYMENT; NORMAL HUMAN; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SOLDIER; BLOOD; CLINICAL TRIAL; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; PATIENT ATTITUDE; PSYCHOLOGY;

ADMINISTRATION, INTRANASAL; ADULT; ANTIBODIES, VIRAL; FEMALE; HEALTHY VOLUNTEERS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA VACCINES; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SELF ADMINISTRATION; VACCINES, ATTENUATED;

EID: 84937521320     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.061     Document Type: Article

References (10)

1. Grabenstein J.D., Nevin R.L. Mass immunization programs: principles and standards. Curr Top Microbiol Immunol 2006, 304:31-51.
2. Riddle M.S., Tribble D.R., Putnam S.D., Mostafa M., Brown T.R., Letizia A., et al. Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle East. Am J Public Health 2008, 98:2199-2206.
3. Soltis B.W., Sanders J.W., Putnam S.D., Tribble D.R., Riddle M.S. Self reported incidence and morbidity of acute respiratory illness among deployed U.S. military in Iraq and Afghanistan. PLoS ONE 2009, 4:e6177.
4. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37:937-943.
5. Coleman B.L., McGeer A.J., Halperin S.A., Langley J.M., Shamout Y., Taddio A., et al. A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. Vaccine 2012, 30:6287-6293.
6. Ambrose C.S., Wu X. The safety and effectiveness of self-administration of intranasal live attenuated influenza vaccine in adults. Vaccine 2013, 31:857-860.
7. Zahn M., Pursiful P., Carrico R., Woods C., Troutman A. Self-immunization with live attenuated influenza vaccine in a mass vaccination clinic. Disaster Med Public Health Prep 2013, 7:215-217.
8. Wang Z., Tobler S., Roayaei J., Eick A. Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA 2009, 301:945-953.
9. Eick A.A., Wang Z., Hughes H., Ford S.M., Tobler S.K. Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members. Vaccine 2009, 27:3568-3575.
10. Phillips C.J., Woolpert T., Sevick C., Faix D., Blair P.J., Crum-Cianflone N.F. Comparison of the effectiveness of trivalent inactivated influenza vaccine and live, attenuated influenza vaccine in preventing influenza-like illness among US military service members, 2006-2009. Clin Infect Dis 2013, 56:11-19.